董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Robert A. Mello | 男 | Director | 66 | 3.00万美元 | 未持股 | 2020-03-30 |
| Marco F. Benedetti | 男 | Director | 60 | 3.40万美元 | 未持股 | 2020-03-30 |
| William J. Laursen | 男 | President, Chief Executive Officer and Director | 49 | 28.00万美元 | 未持股 | 2020-03-30 |
| Rodd E. Friedman | 男 | Director | 53 | 3.00万美元 | 未持股 | 2020-03-30 |
| Andrei Soran | 男 | Chairman of the Board | 60 | 3.29万美元 | 未持股 | 2020-03-30 |
| Jason R. Chambers | 男 | Director | 42 | 3.21万美元 | 未持股 | 2020-03-30 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| William J. Laursen | 男 | President, Chief Executive Officer and Director | 49 | 28.00万美元 | 未持股 | 2020-03-30 |
| Wayne M. Coll | 男 | Chief Financial Officer, Treasurer and Secretary | 56 | 12.79万美元 | 未持股 | 2020-03-30 |
董事简历
中英对照 | 中文 | 英文- Robert A. Mello
-
Robert A. Mello在2015年4月27日被任命到董事会工作。他在Advanced Instruments股份有限公司（Advanced Instruments, Inc，一家领先的为全世界临床、制药、生物技术和微生物实验室提供设备的供应商）担任副总裁和财务总监。2000年4月-2013年7月他被IRIS International股份有限公司（IRIS International, Inc）雇佣担任IRIS 样品流程处理部门的公司副总裁和总裁。Iris International是一家使用在大型医疗机构、商业实验室、临床、医生诊所和研究机构的自动化尿液分析仪器和台式离心机产品的领先供应商。1988-2000年，他是bioMerieux（设计给你笑医疗设备和消费品的公司）制造和的业务执行，包括1996-2000年担任他们在波士顿免疫诊断设备业务的副总裁和临床制造的微生物的一次性用品的副总裁。在加入bioMerieux之前，他担任Medical & Scientific Designs股份有限公司（Medical & Scientific Designs, Inc，一家体外诊断公司，1983年他创立了这个团队）的副总裁，也是Ortho Diagnostics股份有限公司（Ortho Diagnostics, Inc）Johnson & Johnson的部门的高级技术支持工程。他隶属于Diagnostics Marketing Association （DXMA）、American Management Association （AMA）、 American Production and Inventory Control Society （APICS），通过了生产和库存管理（Production and Inventory Management （CPIM））的认证。他拥有莱斯莉大学（Lesley University）管理学士学位和布里斯托尔学院（Bristol College）电子工程ASEE学位。
Robert A. Mello has served as a director since April 2015. Mr. Mello has served as the Vice President and Chief Operating Officer of Advanced Instruments, Inc., a leading supplier of instrumentation for clinical, pharmaceutical, biotechnology and microbiology laboratories around the world, from July 2013 to December 2018. From April 2000 to July 2013 Mr. Mello was employed as Corporate Vice President of IRIS International, Inc. and President of its IRIS Sample Processing division. Iris International is a leading provider of automated urinalysis instrumentation and bench top centrifuge products for use in major medical institutions, commercial laboratories, clinics, doctors' offices and research institutions. From 1988 to 2000 Mr. Mello was an operations executive with bioMerieux, which designs, manufactures and markets medical instruments and consumables, including from 1996 to 2000 as its Vice President of Operations at their Boston Immunodiagnostics facility and Vice President of Disposables Manufacturing-Clinical Microbiology. Prior to joining bioMerieux, Mr. Mello served as Vice President of Operations for Medical & Scientific Designs, Inc., an in-vitro diagnostics company where he joined the founding team in 1983 and as a Senior Technical Support Engineer at Ortho Diagnostics, Inc., a division of Johnson & Johnson. Mr. Mello is affiliated with the Diagnostics Marketing Association DXMA, American Management Association (AMA), American Production and Inventory Control Society (APICS), and is certified in Production and Inventory Management (CPIM). He received his Management, B.S. degree from Lesley University, and his Electrical Engineering, ASEE degree from Bristol College. - Robert A. Mello在2015年4月27日被任命到董事会工作。他在Advanced Instruments股份有限公司（Advanced Instruments, Inc，一家领先的为全世界临床、制药、生物技术和微生物实验室提供设备的供应商）担任副总裁和财务总监。2000年4月-2013年7月他被IRIS International股份有限公司（IRIS International, Inc）雇佣担任IRIS 样品流程处理部门的公司副总裁和总裁。Iris International是一家使用在大型医疗机构、商业实验室、临床、医生诊所和研究机构的自动化尿液分析仪器和台式离心机产品的领先供应商。1988-2000年，他是bioMerieux（设计给你笑医疗设备和消费品的公司）制造和的业务执行，包括1996-2000年担任他们在波士顿免疫诊断设备业务的副总裁和临床制造的微生物的一次性用品的副总裁。在加入bioMerieux之前，他担任Medical & Scientific Designs股份有限公司（Medical & Scientific Designs, Inc，一家体外诊断公司，1983年他创立了这个团队）的副总裁，也是Ortho Diagnostics股份有限公司（Ortho Diagnostics, Inc）Johnson & Johnson的部门的高级技术支持工程。他隶属于Diagnostics Marketing Association （DXMA）、American Management Association （AMA）、 American Production and Inventory Control Society （APICS），通过了生产和库存管理（Production and Inventory Management （CPIM））的认证。他拥有莱斯莉大学（Lesley University）管理学士学位和布里斯托尔学院（Bristol College）电子工程ASEE学位。
- Robert A. Mello has served as a director since April 2015. Mr. Mello has served as the Vice President and Chief Operating Officer of Advanced Instruments, Inc., a leading supplier of instrumentation for clinical, pharmaceutical, biotechnology and microbiology laboratories around the world, from July 2013 to December 2018. From April 2000 to July 2013 Mr. Mello was employed as Corporate Vice President of IRIS International, Inc. and President of its IRIS Sample Processing division. Iris International is a leading provider of automated urinalysis instrumentation and bench top centrifuge products for use in major medical institutions, commercial laboratories, clinics, doctors' offices and research institutions. From 1988 to 2000 Mr. Mello was an operations executive with bioMerieux, which designs, manufactures and markets medical instruments and consumables, including from 1996 to 2000 as its Vice President of Operations at their Boston Immunodiagnostics facility and Vice President of Disposables Manufacturing-Clinical Microbiology. Prior to joining bioMerieux, Mr. Mello served as Vice President of Operations for Medical & Scientific Designs, Inc., an in-vitro diagnostics company where he joined the founding team in 1983 and as a Senior Technical Support Engineer at Ortho Diagnostics, Inc., a division of Johnson & Johnson. Mr. Mello is affiliated with the Diagnostics Marketing Association DXMA, American Management Association (AMA), American Production and Inventory Control Society (APICS), and is certified in Production and Inventory Management (CPIM). He received his Management, B.S. degree from Lesley University, and his Electrical Engineering, ASEE degree from Bristol College.
- Marco F. Benedetti
-
Marco F. Benedetti于2015年7月被任命为董事会成员。Benedetti先生目前担任Canisius College（一所位于纽约西部的私立学院，拥有4000名全职学生，年营业预算为1亿美元）的商业与金融的副总裁 和财务主管。 在2013年加入Canisius College之前，Benedetti先生在Greatbatch, Inc.（是一家上市的全球医疗器械组件制造商，为各种应用提供组件）服务近10年。 他在那里担任过多个高级财务职位，包括财务规划与分析、投资者关系的财务副总裁 和财务主管。 在此之前，Benedetti先生在Ashton-Potter, U.S.A. LTD 和International Imaging Materials, Inc. 担任高级财务职位。Benedetti先生是一名注册会计师，在KPMG, LLP开始他的职业生涯。 他在布法罗State University of New York获得工商管理硕士学位和工商管理理学学士学位。
Marco F. Benedetti has served as a director since July 2015. Mr. Benedetti is currently Vice President for Business & Finance and Treasurer of Canisius College, a private college based in western New York with 4000 full time students and a $100 million annual operating budget. Prior to joining Canisius College in 2013 Mr. Benedetti served nearly ten years at Greatbatch, Inc., a publicly-traded global manufacturer of components for medical devices for a variety of applications. He held a number of senior financial roles there, including Vice President of Finance - Financial Planning and Analysis, Investor Relations and Treasurer. Before that, Mr. Benedetti held senior finance positions at Ashton-Potter, U.S.A. LTD and International Imaging Materials, Inc. Mr. Benedetti is a certified public accountant and began his career at KPMG, LLP. He received a Masters of Business Administration and a Bachelor of Science in Business Administration from the State University of New York at Buffalo. - Marco F. Benedetti于2015年7月被任命为董事会成员。Benedetti先生目前担任Canisius College（一所位于纽约西部的私立学院，拥有4000名全职学生，年营业预算为1亿美元）的商业与金融的副总裁 和财务主管。 在2013年加入Canisius College之前，Benedetti先生在Greatbatch, Inc.（是一家上市的全球医疗器械组件制造商，为各种应用提供组件）服务近10年。 他在那里担任过多个高级财务职位，包括财务规划与分析、投资者关系的财务副总裁 和财务主管。 在此之前，Benedetti先生在Ashton-Potter, U.S.A. LTD 和International Imaging Materials, Inc. 担任高级财务职位。Benedetti先生是一名注册会计师，在KPMG, LLP开始他的职业生涯。 他在布法罗State University of New York获得工商管理硕士学位和工商管理理学学士学位。
- Marco F. Benedetti has served as a director since July 2015. Mr. Benedetti is currently Vice President for Business & Finance and Treasurer of Canisius College, a private college based in western New York with 4000 full time students and a $100 million annual operating budget. Prior to joining Canisius College in 2013 Mr. Benedetti served nearly ten years at Greatbatch, Inc., a publicly-traded global manufacturer of components for medical devices for a variety of applications. He held a number of senior financial roles there, including Vice President of Finance - Financial Planning and Analysis, Investor Relations and Treasurer. Before that, Mr. Benedetti held senior finance positions at Ashton-Potter, U.S.A. LTD and International Imaging Materials, Inc. Mr. Benedetti is a certified public accountant and began his career at KPMG, LLP. He received a Masters of Business Administration and a Bachelor of Science in Business Administration from the State University of New York at Buffalo.
- William J. Laursen
-
WilliamJ.Laursen自2018年11月28日起担任公司总裁，首席执行官兼董事。2012年1月至2018年11月，他担任The Coghlin Companies，Inc.的执行Vice President、销售和战略，该公司是一家提供工程服务的私营上市时间服务公司，面向包括军事和医疗器械在内的各种市场的复杂机电和电光器件及设备的原型和合同制造。Laursen从2003年4月到2009年10月担任M2America Corp.（一家工程和制造公司，专注于光学媒体制造设备）总裁和BOA成员。Laursen自2009年起担任Maks，LLC（一家项目导向公司，提供战略规划、业务开发和系统实施）负责人。
William J. Laursen has served as the Company’s President, Chief Executive Officer and Director since November 28 2018. From January 2012 to November 2018 he was the Executive Vice President, Sales and Strategy of The Coghlin Companies, Inc., a privately held, time to market services company, offering engineering, prototyping and contract manufacturing of complex electro-mechanical and electro-optical devices and equipment for a variety of markets including military and medical devices. From April 2003 until October 2009 Mr. Laursen served as President and BOA member for M2 America Corp. an engineering and manufacturing firm focused on Optical media manufacturing equipment. Since 2009 Mr. Laursen has also been a principal of MAKS, LLC, a project oriented company that provides strategic planning, business development and systems implementation. - WilliamJ.Laursen自2018年11月28日起担任公司总裁，首席执行官兼董事。2012年1月至2018年11月，他担任The Coghlin Companies，Inc.的执行Vice President、销售和战略，该公司是一家提供工程服务的私营上市时间服务公司，面向包括军事和医疗器械在内的各种市场的复杂机电和电光器件及设备的原型和合同制造。Laursen从2003年4月到2009年10月担任M2America Corp.（一家工程和制造公司，专注于光学媒体制造设备）总裁和BOA成员。Laursen自2009年起担任Maks，LLC（一家项目导向公司，提供战略规划、业务开发和系统实施）负责人。
- William J. Laursen has served as the Company’s President, Chief Executive Officer and Director since November 28 2018. From January 2012 to November 2018 he was the Executive Vice President, Sales and Strategy of The Coghlin Companies, Inc., a privately held, time to market services company, offering engineering, prototyping and contract manufacturing of complex electro-mechanical and electro-optical devices and equipment for a variety of markets including military and medical devices. From April 2003 until October 2009 Mr. Laursen served as President and BOA member for M2 America Corp. an engineering and manufacturing firm focused on Optical media manufacturing equipment. Since 2009 Mr. Laursen has also been a principal of MAKS, LLC, a project oriented company that provides strategic planning, business development and systems implementation.
- Rodd E. Friedman
-
RoddE.Friedman自2017年7月21日被任命为公司董事。Friedman先生是私人投资公司Ref Securities&Co.“；Ref”；的创始人和管理成员。Friedman先生自1991年以来通过Ref主要从事公共和私人股票及衍生品的投资。创立Ref公司之前，Friedman先生曾担任O’；Connor and Associates（美国证券交易所的做市商）的期权交易员。Friedman先生在纽约大学斯特恩商学院（NYU Stern School of Business）获得金融理学学士学位。
Rodd E. Friedman has served as a director of the Company since his appointment on July 21 2017. Mr. Friedman is the founder and managing member of REF Securities & Co. “REF”, a private investment firm. Mr. Friedman, through REF, has been principally engaged in investing in public and private equities and derivatives since 1991. Prior to founding REF, Mr. Friedman was employed as an options trader at O’Connor and Associates, a market maker on the American Stock Exchange. Mr. Friedman received a Bachelor of Science in Finance from NYU Stern School of Business. - RoddE.Friedman自2017年7月21日被任命为公司董事。Friedman先生是私人投资公司Ref Securities&Co.“；Ref”；的创始人和管理成员。Friedman先生自1991年以来通过Ref主要从事公共和私人股票及衍生品的投资。创立Ref公司之前，Friedman先生曾担任O’；Connor and Associates（美国证券交易所的做市商）的期权交易员。Friedman先生在纽约大学斯特恩商学院（NYU Stern School of Business）获得金融理学学士学位。
- Rodd E. Friedman has served as a director of the Company since his appointment on July 21 2017. Mr. Friedman is the founder and managing member of REF Securities & Co. “REF”, a private investment firm. Mr. Friedman, through REF, has been principally engaged in investing in public and private equities and derivatives since 1991. Prior to founding REF, Mr. Friedman was employed as an options trader at O’Connor and Associates, a market maker on the American Stock Exchange. Mr. Friedman received a Bachelor of Science in Finance from NYU Stern School of Business.
- Andrei Soran
-
Andrei Soran自2017年12月8日起担任公司董事。他于2019年5月23日的公司年会上当选为董事长。Soran先生于2019年5月至2019年9月担任Trident USA Health的首席执行官，Trident USA Health是后急性护理中最大的移动诊断服务提供商。该公司雇用医生，护士从业人员，放射技师和静脉血清学家，在患者居住的地点提供服务。他自2017年8月起担任NovaSeek Research，Inc.“；NovaSeek”；的首席执行官。NovaSeek是用于研究（“；CDNR”；）服务的基于云的临床数据网络的提供商。在Novaseek之前，他于2016年7月至2017年7月担任Verity Health Systems的首席执行官，并于2016年4月至2016年7月担任Verity Health Systems的总裁兼首席运营官，Verity Health Systems是加利福尼亚州雷德伍德市的一家多设施医院和梦百合网络。索兰此前曾于2014年7月至2016年4月在底特律医疗中心（Detroit Medical Center）担任首席运营官和执行副总裁。他还从2013年8月到2014年6月担任Tenet’；s，Huron Valley-Sinai Hospital，DMC Surgery Hospital的总裁。加入Tenet之前，Soran从2006年4月到2013年6月担任Framingham，Massachusetts Metrowest Medical Center（一家先锋健康系统设施）首席执行官。Vanguard于2013年被Tenet收购。Soran先生拥有以色列特拉维夫大学（Tel Aviv University）物理治疗学士学位和波士顿大学大都会学院（Boston University-Metropolitan College）工商管理硕士学位。
Andrei Soran has served as a director of the Company since December 8 2017. He was elected to Chairman of the Board at the Company’s May 23 2019 Annual Meeting. Mr. Soran served from May 2019 to September 2019 as CEO of Trident USA Health, the largest provider of mobile diagnostic services in Post Acute Care. The company employs Physicians, Nurse Practitioners, Radiology Technicians, and Phlebotomists providing services at the sites where the patients reside. He served as the CEO of Novaseek Research, Inc. “Novaseek”, since August 2017. Novaseek is a provider of cloud-based Clinical Data Network for Research (“CDNR”) services. Before Novaseek, he served from July, 2016 to July, 2017 as the CEO and from April, 2016 to July, 2016 as the President and Chief Operating Officer of Verity Health Systems, a Redwood City, California multi-facility hospital, and healthcare network. Mr. Soran previously served from July, 2014 to April, 2016 as COO and Executive VP at Tenet Healthcare Corporation’s (“Tenet”) Detroit Medical Center. He also served from August, 2013 to June, 2014 as president of Tenet’s, Huron Valley-Sinai Hospital, DMC Surgery Hospital. Prior to Tenet, from April, 2006 to June, 2013 Mr. Soran served as CEO of Framingham, Massachusetts based MetroWest Medical Center, a Vanguard Health Systems facility. Vanguard was acquired by Tenet in 2013. Mr. Soran holds a Bachelor degree in Physical Therapy from Tel Aviv University in Israel and a Master’s degree in Business Administration and Management from Boston University-Metropolitan College. - Andrei Soran自2017年12月8日起担任公司董事。他于2019年5月23日的公司年会上当选为董事长。Soran先生于2019年5月至2019年9月担任Trident USA Health的首席执行官，Trident USA Health是后急性护理中最大的移动诊断服务提供商。该公司雇用医生，护士从业人员，放射技师和静脉血清学家，在患者居住的地点提供服务。他自2017年8月起担任NovaSeek Research，Inc.“；NovaSeek”；的首席执行官。NovaSeek是用于研究（“；CDNR”；）服务的基于云的临床数据网络的提供商。在Novaseek之前，他于2016年7月至2017年7月担任Verity Health Systems的首席执行官，并于2016年4月至2016年7月担任Verity Health Systems的总裁兼首席运营官，Verity Health Systems是加利福尼亚州雷德伍德市的一家多设施医院和梦百合网络。索兰此前曾于2014年7月至2016年4月在底特律医疗中心（Detroit Medical Center）担任首席运营官和执行副总裁。他还从2013年8月到2014年6月担任Tenet’；s，Huron Valley-Sinai Hospital，DMC Surgery Hospital的总裁。加入Tenet之前，Soran从2006年4月到2013年6月担任Framingham，Massachusetts Metrowest Medical Center（一家先锋健康系统设施）首席执行官。Vanguard于2013年被Tenet收购。Soran先生拥有以色列特拉维夫大学（Tel Aviv University）物理治疗学士学位和波士顿大学大都会学院（Boston University-Metropolitan College）工商管理硕士学位。
- Andrei Soran has served as a director of the Company since December 8 2017. He was elected to Chairman of the Board at the Company’s May 23 2019 Annual Meeting. Mr. Soran served from May 2019 to September 2019 as CEO of Trident USA Health, the largest provider of mobile diagnostic services in Post Acute Care. The company employs Physicians, Nurse Practitioners, Radiology Technicians, and Phlebotomists providing services at the sites where the patients reside. He served as the CEO of Novaseek Research, Inc. “Novaseek”, since August 2017. Novaseek is a provider of cloud-based Clinical Data Network for Research (“CDNR”) services. Before Novaseek, he served from July, 2016 to July, 2017 as the CEO and from April, 2016 to July, 2016 as the President and Chief Operating Officer of Verity Health Systems, a Redwood City, California multi-facility hospital, and healthcare network. Mr. Soran previously served from July, 2014 to April, 2016 as COO and Executive VP at Tenet Healthcare Corporation’s (“Tenet”) Detroit Medical Center. He also served from August, 2013 to June, 2014 as president of Tenet’s, Huron Valley-Sinai Hospital, DMC Surgery Hospital. Prior to Tenet, from April, 2006 to June, 2013 Mr. Soran served as CEO of Framingham, Massachusetts based MetroWest Medical Center, a Vanguard Health Systems facility. Vanguard was acquired by Tenet in 2013. Mr. Soran holds a Bachelor degree in Physical Therapy from Tel Aviv University in Israel and a Master’s degree in Business Administration and Management from Boston University-Metropolitan College.
- Jason R. Chambers
-
自2006年以来，Jason R. Chambers一直担任本公司董事。从2002年至今他担任Mountain Brook Water总裁，这是一家水装瓶及分销公司，从2001年至今一直担任The Chambers Medical Foundation顾问，这是一家私人基金会“基金会”，协助评估医疗补助申请。他2011年被任命为基金会理事，该基金会实益拥有约10个本公司已发行普通股。他获Vanderbilt大学工程学院理学士学位，Vanderbilt大学欧文管理研究生院金融和市场营销的工商管理硕士学位。他也是Dana-Farber癌症研究所血液肿瘤来访委员会委员。
Jason R. Chambers has served as a director of the Company since 2006. He served as Chairman of the Board from July 2016 through May 2019. Mr. Chambers has served as VP Business Development for DS Services of America, Inc. from January 2020 to present. Mr. Chambers previously served as President of Mountain Brook Water, a water bottling and distribution company, from 2002 to 2019 and from 2001 to present has served as a consultant assisting The Chambers Medical Foundation, a private foundation the "Foundation", in assessing medical grant applications. Mr. Chambers was appointed Trustee of the Foundation in 2011. Mr. Chambers holds a Bachelor of Science degree from Vanderbilt University School of Engineering and a Masters of Business Administration degree from Owen Graduate School of Management, Vanderbilt University with a concentration in finance and marketing. Mr. Chambers is a member of Vanderbilt’s School of Engineering Board of Visitors. - 自2006年以来，Jason R. Chambers一直担任本公司董事。从2002年至今他担任Mountain Brook Water总裁，这是一家水装瓶及分销公司，从2001年至今一直担任The Chambers Medical Foundation顾问，这是一家私人基金会“基金会”，协助评估医疗补助申请。他2011年被任命为基金会理事，该基金会实益拥有约10个本公司已发行普通股。他获Vanderbilt大学工程学院理学士学位，Vanderbilt大学欧文管理研究生院金融和市场营销的工商管理硕士学位。他也是Dana-Farber癌症研究所血液肿瘤来访委员会委员。
- Jason R. Chambers has served as a director of the Company since 2006. He served as Chairman of the Board from July 2016 through May 2019. Mr. Chambers has served as VP Business Development for DS Services of America, Inc. from January 2020 to present. Mr. Chambers previously served as President of Mountain Brook Water, a water bottling and distribution company, from 2002 to 2019 and from 2001 to present has served as a consultant assisting The Chambers Medical Foundation, a private foundation the "Foundation", in assessing medical grant applications. Mr. Chambers was appointed Trustee of the Foundation in 2011. Mr. Chambers holds a Bachelor of Science degree from Vanderbilt University School of Engineering and a Masters of Business Administration degree from Owen Graduate School of Management, Vanderbilt University with a concentration in finance and marketing. Mr. Chambers is a member of Vanderbilt’s School of Engineering Board of Visitors.
高管简历
中英对照 | 中文 | 英文- William J. Laursen
WilliamJ.Laursen自2018年11月28日起担任公司总裁，首席执行官兼董事。2012年1月至2018年11月，他担任The Coghlin Companies，Inc.的执行Vice President、销售和战略，该公司是一家提供工程服务的私营上市时间服务公司，面向包括军事和医疗器械在内的各种市场的复杂机电和电光器件及设备的原型和合同制造。Laursen从2003年4月到2009年10月担任M2America Corp.（一家工程和制造公司，专注于光学媒体制造设备）总裁和BOA成员。Laursen自2009年起担任Maks，LLC（一家项目导向公司，提供战略规划、业务开发和系统实施）负责人。
William J. Laursen has served as the Company’s President, Chief Executive Officer and Director since November 28 2018. From January 2012 to November 2018 he was the Executive Vice President, Sales and Strategy of The Coghlin Companies, Inc., a privately held, time to market services company, offering engineering, prototyping and contract manufacturing of complex electro-mechanical and electro-optical devices and equipment for a variety of markets including military and medical devices. From April 2003 until October 2009 Mr. Laursen served as President and BOA member for M2 America Corp. an engineering and manufacturing firm focused on Optical media manufacturing equipment. Since 2009 Mr. Laursen has also been a principal of MAKS, LLC, a project oriented company that provides strategic planning, business development and systems implementation.- WilliamJ.Laursen自2018年11月28日起担任公司总裁，首席执行官兼董事。2012年1月至2018年11月，他担任The Coghlin Companies，Inc.的执行Vice President、销售和战略，该公司是一家提供工程服务的私营上市时间服务公司，面向包括军事和医疗器械在内的各种市场的复杂机电和电光器件及设备的原型和合同制造。Laursen从2003年4月到2009年10月担任M2America Corp.（一家工程和制造公司，专注于光学媒体制造设备）总裁和BOA成员。Laursen自2009年起担任Maks，LLC（一家项目导向公司，提供战略规划、业务开发和系统实施）负责人。
- William J. Laursen has served as the Company’s President, Chief Executive Officer and Director since November 28 2018. From January 2012 to November 2018 he was the Executive Vice President, Sales and Strategy of The Coghlin Companies, Inc., a privately held, time to market services company, offering engineering, prototyping and contract manufacturing of complex electro-mechanical and electro-optical devices and equipment for a variety of markets including military and medical devices. From April 2003 until October 2009 Mr. Laursen served as President and BOA member for M2 America Corp. an engineering and manufacturing firm focused on Optical media manufacturing equipment. Since 2009 Mr. Laursen has also been a principal of MAKS, LLC, a project oriented company that provides strategic planning, business development and systems implementation.
- Wayne M. Coll
WayneM.Coll自2019年7月15日起担任公司首席财务官，司库兼首席会计和财务官。科尔先生于2018年10月至2019年5月担任私人医疗设备制造商Keystone Dental，Inc.的首席财务官。从2013年10月至2018年9月，科尔先生担任Modern Dental Laboratory，USA LLC的首席财务官兼运营官，该公司是医疗器械制造商，也是香港交易所上市的Modern Dental Group Limited的北美部门:3600。Coll先生从2011年11月开始担任PluroMed，Inc.的首席财务官，该公司是一家医疗设备制造商，被健赞公司收购，他在该公司一直任职到2013年9月。从1990年10月到2011年5月，Coll先生担任多个高级财务管理职位，包括National Dentex Corporation（纳斯达克市场代码:NADX）的首席财务官。
Wayne M. Coll has over 30 years of senior financial executive experience, primarily with medical device based binesses. He formerly served as Chief Financial Officer for Flowonix Medical Incorporated (July 2021 June 2023), Micron Products, Inc. (July 2019 – July 2021), Keystone Dental, Inc. (September 2018 – May 2019), Modern Dental Laboratory A, LLC (September 2013 – September 2018) and National Dentex Corporation (2007 2011). Mr. Coll received a B.S. in Biness Administration and Accounting from the University of Loll, and an M.B.A. from the University of Massachetts Loll.- WayneM.Coll自2019年7月15日起担任公司首席财务官，司库兼首席会计和财务官。科尔先生于2018年10月至2019年5月担任私人医疗设备制造商Keystone Dental，Inc.的首席财务官。从2013年10月至2018年9月，科尔先生担任Modern Dental Laboratory，USA LLC的首席财务官兼运营官，该公司是医疗器械制造商，也是香港交易所上市的Modern Dental Group Limited的北美部门:3600。Coll先生从2011年11月开始担任PluroMed，Inc.的首席财务官，该公司是一家医疗设备制造商，被健赞公司收购，他在该公司一直任职到2013年9月。从1990年10月到2011年5月，Coll先生担任多个高级财务管理职位，包括National Dentex Corporation（纳斯达克市场代码:NADX）的首席财务官。
- Wayne M. Coll has over 30 years of senior financial executive experience, primarily with medical device based binesses. He formerly served as Chief Financial Officer for Flowonix Medical Incorporated (July 2021 June 2023), Micron Products, Inc. (July 2019 – July 2021), Keystone Dental, Inc. (September 2018 – May 2019), Modern Dental Laboratory A, LLC (September 2013 – September 2018) and National Dentex Corporation (2007 2011). Mr. Coll received a B.S. in Biness Administration and Accounting from the University of Loll, and an M.B.A. from the University of Massachetts Loll.